Limited by pharmacologic strategies, many physicians are increasingly turning to surgery as an option to treat their obese patients. Although bariatric surgery is currently our most effective strategy to initiate sustained weight loss and improvements in the many associated comorbidities, the necessary infrastructure for surgery limits widespread implementation. However, we have an opportunity to use the knowledge gained from both clinical and preclinical research to drive alternative strategies to treat obesity, be they pharmacologic or simpler operative interventions.